At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Xanthohumol Metabolism and Signature (XMaS) in Healthy Adults
In Brief
A Phase 1 clinical trial evaluating Xanthohumol and Placebo oral capsule for Healthy. Active but no longer recruiting, targeting 30 participants across 1 site.
Detailed Summary
A pilot study to assess the safety and tolerability of oral xanthohumol in humans, to identify a biological signature of xanthohumol exposure, and to characterize the role of xanthohumol metabolism by intestinal microorganisms in that signature.
Study Details
Timeline
Interventions
The xanthohumol supplement will be administered in a capsule. Participants in the experimental arm will consume the capsule once per day, with the first meal. The intervention will extend for 8 weeks.
The placebo (vehicle) will be administered in a capsule. Participants in the placebo arm will consume the capsule once per day, with the first meal.